No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annualized revenue (TTM) · by quarter, last 8
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T13:20:30.223Z. Latest historical point 2026-10-05.
The latest delayed quote for Aimei Health Technology Co., Ltd (AFJK) stock was $12.35 as of Oct 5, 2026, 4:00 PM EDT, up 1.22% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +9.0%
Aimei Health Technology Co., Ltd. currently lacks substantial business operations.
Shell Companies · New York City, NY
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-0.03
vs Estimate
N/A
Revenue
$0.00
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1AFJK | $39.10M | $12.35 | +1.22% | +8.96% | N/A | N/A | N/A |
| 2KG | $38.42M | $4.91 | -6.30% | -80.85% | N/A | N/A | vs AFJK |
| 3INV | $41.28M | $0.52 | +2.32% | -89.62% | N/A | N/A | vs AFJK |
| 4GROW | $36.77M | $2.90 | +1.40% | +9.72% | -10.69% | +8.44% | vs AFJK |
| 5DTSQ | $42.22M | $11.56 | -0.20% | +10.55% | N/A | N/A | vs AFJK |
| 6AVAT | $44.75M | $1.88 | +2.73% | N/A | N/A | N/A | vs AFJK |
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$12.35
High
N/A
